Search

Your search keyword '"López-Campos, José Luis"' showing total 613 results
Start Over Author "López-Campos, José Luis" Publication Year Range Last 50 years
613 results on '"López-Campos, José Luis"'

1. Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized Trial

Author

Agusti, Alvar, Lopez-Campos, José Luis, Miravitlles, Marc, Soler-Cataluña, Juan Jose, Marin, Jose Maria, Cosio, Borja G., Alcázar-Navarrete, Bernardino, Echave-Sustaeta, Jose Maria, Casanova, Ciro, Peces-Barba, German, de-Torres, Juan Pablo, Fernandez-Villar, Alberto, Ancochea, Julio, Villar-Alvarez, Felipe, Roman-Rodriguez, Miguel, Molina, Jesus, Garcia-Rivero, Juan Luis, Gonzalez, Cruz, Sobradillo, Patricia, Faner, Rosa, Peña, Carolina, Sharma, Raj, Izquierdo, José Luis, and Celli, Bartolome R.

Published
2024
Full Text
View/download PDF

2. Heteroatom-tagged proteomics of lung cancer and chronic obstructive pulmonary disease human serum reveal alterations in selenoproteins

Author

Callejón-Leblic, Belén, Sánchez Espirilla, Saida, Gotera-Rivera, Carolina, Santana, Rafael, Díaz-Olivares, Isabel, María Marín Trigo, José, Casanova Macario, Ciro, Cosio, Borja G., Fuster, Antonia, Solanes García, Ingrid, de-Torres, Juan P., Feu Collado, Nuria, Cabrera Lopez, Carlos, Amado Diago, Carlos, Romero Plaza, Amparo, Padrón Fraysse, Luis Alejandro, Márquez Martín, Eduardo, Marín Royo, Margarit, Balcells Vilarnau, Eva, Llunell Casanovas, Antonia, Martínez González, Cristina, Bautista Galdíz Iturri, Juan, Lacárcel Bautista, Celia, Gómez-Ariza, José Luis, Pereira-Vega, Antonio, Seijo, Luis, López-Campos, José Luis, Peces-Barba, Germán, and García-Barrera, Tamara

Published
2024
Full Text
View/download PDF

3. COVID-19’s impact on care practice for alpha-1-antitrypsin deficiency patients

Author

Calle Rubio, Myriam, López-Campos, José Luis, Miravitlles, Marc, Michel de la Rosa, Francisco Javier, Hernández Pérez, José María, Montero Martínez, Carmen, Montoro Ronsano, José Bruno, Casas Maldonado, Francisco, Rodríguez Hermosa, Juan Luis, Tabernero Huguet, Eva María, Martínez Sesmero, José Manuel, Martínez Rivera, Carlos, Callejas González, Francisco Javier, and Torres Durán, María

Published
2023
Full Text
View/download PDF

4. Correction: Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

Author

Miravitlles, Marc, Turner, Alice M., Torres-Duran, María, Tanash, Hanan, Rodríguez-García, Carlota, López-Campos, José Luis, Chlumsky, Jan, Guimaraes, Catarina, Rodríguez-Hermosa, Juan Luis, Corsico, Angelo, Martinez-González, Cristina, Hernández-Pérez, José María, Bustamante, Ana, Parr, David G., Casas-Maldonado, Francisco, Hecimovic, Ana, Janssens, Wim, Lara, Beatriz, Barrecheguren, Miriam, González, Cruz, Stolk, Jan, Esquinas, Cristina, and Clarenbach, Christian F.

Published
2023
Full Text
View/download PDF

6. Sex-Differences in Alpha-1 Antitrypsin Deficiency: Data From the EARCO Registry

Author

Ersöz, Hilal, Torres-Durán, María, Turner, Alice M., Tanash, Hanan, García, Carlota Rodríguez, Corsico, Angelo Guido, López-Campos, José Luis, Miravitlles, Marc, Clarenbach, Christian F., Chapman, Kenneth R., Pérez, Jose Mª Hernández, Guimarães, Catarina, Bartošovská, Eva, Greulich, Timm, Barrecheguren, Miriam, Koczulla, Andreas Rembert, Höger, Philipp, Rivera, Arturo Olivares, Herth, Felix, and Trudzinski, Franziska C.

Published
2024
Full Text
View/download PDF

16. Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry

Author

Miravitlles, Marc, Turner, Alice M., Torres-Duran, María, Tanash, Hanan, Rodríguez-García, Carlota, López-Campos, José Luis, Chlumsky, Jan, Guimaraes, Catarina, Rodríguez-Hermosa, Juan Luis, Corsico, Angelo, Martinez-González, Cristina, Hernández-Pérez, José María, Bustamante, Ana, Parr, David G., Casas-Maldonado, Francisco, Hecimovic, Ana, Janssens, Wim, Lara, Beatriz, Barrecheguren, Miriam, González, Cruz, Stolk, Jan, Esquinas, Cristina, and Clarenbach, Christian F.

Published
2022
Full Text
View/download PDF

23. A Pilot Study on Proteomic Predictors of Mortality in Stable COPD.

Author

Enríquez-Rodríguez, Cesar Jessé, Casadevall, Carme, Faner, Rosa, Pascual-Guardia, Sergi, Castro-Acosta, Ady, López-Campos, José Luis, Peces-Barba, Germán, Seijo, Luis, Caguana-Vélez, Oswaldo Antonio, Monsó, Eduard, Rodríguez-Chiaradia, Diego, Barreiro, Esther, Cosío, Borja G., Agustí, Alvar, Gea, Joaquim, and Group, on behalf of the BIOMEPOC

Subjects
CHRONIC obstructive pulmonary disease, PEPTIDE mass fingerprinting, ARTIFICIAL intelligence, PROTEOMICS, DEATH forecasting
Abstract

Chronic Obstructive Pulmonary Disease (COPD) is the third leading cause of global mortality. Despite clinical predictors (age, severity, comorbidities, etc.) being established, proteomics offers comprehensive biological profiling to obtain deeper insights into COPD pathophysiology and survival prognoses. This pilot study aimed to identify proteomic footprints that could be potentially useful in predicting mortality in stable COPD patients. Plasma samples from 40 patients were subjected to both blind (liquid chromatography–mass spectrometry) and hypothesis-driven (multiplex immunoassays) proteomic analyses supported by artificial intelligence (AI) before a 4-year clinical follow-up. Among the 34 patients whose survival status was confirmed (mean age 69 ± 9 years, 29.5% women, FEV1 42 ± 15.3% ref.), 32% were dead in the fourth year. The analysis identified 363 proteins/peptides, with 31 showing significant differences between the survivors and non-survivors. These proteins predominantly belonged to different aspects of the immune response (12 proteins), hemostasis (9), and proinflammatory cytokines (5). The predictive modeling achieved excellent accuracy for mortality (90%) but a weaker performance for days of survival (Q2 0.18), improving mildly with AI-mediated blind selection of proteins (accuracy of 95%, Q2 of 0.52). Further stratification by protein groups highlighted the predictive value for mortality of either hemostasis or pro-inflammatory markers alone (accuracies of 95 and 89%, respectively). Therefore, stable COPD patients' proteomic footprints can effectively forecast 4-year mortality, emphasizing the role of inflammatory, immune, and cardiovascular events. Future applications may enhance the prognostic precision and guide preventive interventions. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

24. The long-term sequelae of COVID-19: an international consensus on research priorities for patients with pre-existing and new-onset airways disease

Author

Adeloye, Davies, Elneima, Omer, Daines, Luke, Poinasamy, Krisnah, Quint, Jennifer K, Walker, Samantha, Brightling, Chris E, Siddiqui, Salman, Hurst, John R, Chalmers, James D, Pfeffer, Paul E, Novotny, Petr, Drake, Thomas M, Abdollahi, Mohammad, Agarwal, Dhiraj, Al-Lehebi, Riyad, Barnes, Peter J, Bayry, Jagadeesh, Bonay, Marcel, Bont, Louis J, Bourdin, Arnaud, Brown, Thomas, Caramori, Gaetano, Chan, Amy Hai Yan, Dockrell, David H, Doe, Simon, Duckers, Jamie, D'Urzo, Anthony, Ekström, Magnus, Esteban, Cristóbal, Greene, Catherine M, Gupta, Atul, Ingram, Jennifer L, Khoo, Ee Ming, Ko, Fanny Wai San, Koppelman, Gerard H, Lipworth, Brian J, Lisspers, Karin, Loebinger, Michael, Lopez-Campos, Jose Luis, Maddocks, Matthew, Mannino, David, Martinez-Garcia, Miguel A, Mcnamara, Renae, Miravitlles, Marc, Ndarukwa, Pisirai, Pooler, Alison, Rhee, Chin Kook, Schwarz, Peter, Shaw, Dominick, Steiner, Michael, Tai, Andrew, Ulrik, Charlotte Suppli, Walker, Paul, Williams, Michelle C, Heaney, Liam G, Rudan, Igor, Sheikh, Aziz, and De Soyza, Anthony

Published
2021
Full Text
View/download PDF

27. COPD: systemic proteomic profiles in frequent and infrequent exacerbators

Author

Enríquez-Rodríguez, Cesar Jessé, primary, Casadevall, Carme, additional, Faner, Rosa, additional, Castro-Costa, Ady, additional, Pascual-Guàrdia, Sergi, additional, Seijó, Luis, additional, López-Campos, José Luis, additional, Peces-Barba, Germán, additional, Monsó, Eduard, additional, Barreiro, Esther, additional, Cosío, Borja G., additional, Agustí, Alvar, additional, and Gea, Joaquim, additional

Published
2024
Full Text
View/download PDF

28. Global mortality and readmission rates following COPD exacerbation-related hospitalization: a meta-analysis of 65945 individual patients

Author

Waeijen-Smit, Kiki, primary, Crutsen, Mieke, additional, Keene, Spencer, additional, Miravitlles, Marc, additional, Crisafulli, Ernesto, additional, Torres, Antoni, additional, Mueller, Christian, additional, Schuetz, Philipp, additional, Ringbæk, Thomas J., additional, Fabbian, Fabio, additional, Mekov, Evgeni, additional, Harries, Timothy H., additional, Lun, Chung-tat, additional, Ergan, Begum, additional, Esteban, Cristóbal, additional, Quintana Lopez, Jose M., additional, López-Campos, José Luis, additional, Chang, Catherina L., additional, Hancox, Robert J., additional, Shafuddin, Eskandarain, additional, Ellis, Hollie, additional, Janson, Christer, additional, Suppli Ulrik, Charlotte, additional, Gudmundsson, Gunnar, additional, Epstein, Danny, additional, Dominguez, José, additional, Lacoma, Alicia, additional, Osadnik, Christian, additional, Alia, Inmaculada, additional, Spannella, Francesco, additional, Karakurt, Zuhal, additional, Mehravaran, Hossein, additional, Utens, Cecile, additional, de Kruif, Martijn D., additional, Ko, Fanny Wai San, additional, Trethewey, Samuel P., additional, Turner, Alice M., additional, Bumbacea, Dragos, additional, Murphy, Patrick B., additional, Vermeersch, Kristina, additional, Zilberman-Itskovich, Shani, additional, Steer, John, additional, Echevarria, Carlos, additional, Bourke, Stephen C., additional, Lane, Nicholas, additional, de Batlle, Jordi, additional, Sprooten, Roy T. M., additional, Russell, Richard, additional, Faverio, Paola, additional, Cross, Jane L., additional, Prins, Hendrik J., additional, Spruit, Martijn A., additional, Simons, Sami O., additional, Houben-Wilke, Sarah, additional, and Franssen, Frits M. E., additional

Published
2024
Full Text
View/download PDF

31. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias

Author

Villar-Álvarez, Felipe, Martínez-García, Miguel Ángel, Jiménez, David, Fariñas-Guerrero, Fernando, Ortiz de Lejarazu-Leonardo, Raúl, López-Campos, José Luis, Blanco-Aparicio, Marina, Royo-Crespo, Íñigo, García-Ortega, Alberto, Trilla-García, Antoni, Trujillo-Reyes, Juan Carlos, Fernández-Prada, María, Díaz-Pérez, David, Laporta-Hernández, Rosalía, Valenzuela, Claudia, Menéndez, Rosario, and de la Rosa-Carrillo, David

Published
2021
Full Text
View/download PDF

35. Documento de consenso sobre el diagnóstico y tratamiento de la infección bronquial crónica en la enfermedad pulmonar obstructiva crónica

Author

Javier Callejas, Francisco, Cervera Juan, Ángela, Palop Cervera, Marta, Fuster Gomila, Antonia, Marín Tapia, Alicia, Pomares Amigo, Xavier, Torres González, Mirian, Hernández Borge, Jacinto, Pérez Chica, Gerardo, Jimeno Galván, Rocío, Golpe Gómez, Rafael, Marcos Rodríguez, Pedro J., Cebollero Rivas, Pilar, Tabernero Huguet, Eva, Álvarez Martínez, Carlos, Prados Sánchez, Concha, Martínez Garcerán, José Javier, Peñalver Mellado, Carlos, García Clemente, Marta, Rodríguez López, Juan, Figueira Gonçalves, Juan Marco, José Pérez Mendoza, Guillermo, Hernández Hernández, Jesús, Amado Diago, Carlos, Pérez Giménez, Laura, Moya Álvarez, Virginia, Palou Rotger, Alexandre, Girón Moreno, Rosa, Blanco Aparicio, Marina, Navarro Rolón, Annie, Sibila, Oriol, Miravitlles Fernández, Marc, José Soler Cataluña, Juan, Alberto Fernández Villar, José, Peces-Barba Romero, Germán, de la Rosa Carrillo, David, López-Campos, José Luís, Alcázar Navarrete, Bernardino, Calle Rubio, Myriam, Cantón Moreno, Rafael, García-Rivero, Juan Luis, Máiz Carro, Luís, Olveira Fuster, Casilda, and Martínez-García, Miguel Ángel

Published
2020
Full Text
View/download PDF

36. Risk of lung disease in the PI*SS genotype of alpha-1 antitrypsin: an EARCO research project.

Author

Martín, Teresa, Guimarães, Catarina, Esquinas, Cristina, Torres-Duran, Maria, Turner, Alice M., Tanash, Hanan, Rodríguez-García, Carlota, Corsico, Angelo, López-Campos, José Luis, Bartošovská, Eva, Stæhr Jensen, Jens-Ulrik, Hernández-Pérez, José María, Sucena, Maria, and Miravitlles, Marc

Subjects
LUNG diseases, TRYPSIN inhibitors, GENOTYPES, CONFOUNDING variables, DISEASE prevalence, ALPHA 1-antitrypsin deficiency, INTERSTITIAL lung diseases
Abstract

Background: The PI*S variant is one of the most prevalent mutations within alpha-1 antitrypsin deficiency (AATD). The risk of developing AATD-related lung disease in individuals with the PI*SS genotype is poorly defined despite its substantial prevalence. Our study aimed to characterize this genotype and its risk for lung disease and compare it with the PI*ZZ and PI*SZ genotypes using data from the European Alpha-1 antitrypsin Deficiency Research Collaboration international registry. Method: Demographic, clinical, functional, and quality of life (QoL) parameters were assessed to compare the PI*SS characteristics with the PI*SZ and PI*ZZ controls. A propensity score with 1:3 nearest-neighbour matching was performed for the most important confounding variables. Results: The study included 1007 individuals, with PI*SS (n = 56; 5.6%), PI*ZZ (n = 578; 57.4%) and PI*SZ (n = 373; 37.0%). The PI*SS population consisted of 58.9% men, with a mean age of 59.2 years and a mean FEV1(% predicted) of 83.4%. Compared to PI*ZZ individuals they had less frequent lung disease (71.4% vs. 82.2%, p = 0.037), COPD (41.4% vs. 60%, p = 0.002), and emphysema (23.2% vs. 51.9%, p < 0.001) and better preserved lung function, fewer exacerbations, lower level of dyspnoea, and better QoL. In contrast, no significant differences were found in the prevalence of lung diseases between PI*SS and PI*SZ, or lung function parameters, exacerbations, dyspnoea, or QoL. Conclusions: We found that, as expected, the risk of lung disease associated with the PI*SS genotype is significantly lower compared with PI*ZZ, but does not differ from that observed in PI*SZ individuals, despite having higher serum AAT levels. Trial registration: www.clinicaltrials.gov (ID: NCT04180319). [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

37. Occult cancer in patients with unprovoked venous thromboembolism: A nested case-control study.

Author

Sánchez-López, Verónica, Marín-Romero, Samira, Ferrer-Galván, Marta, Elías-Hernández, Teresa, Beristain, José Luis Lobo, Quincoces, Aitor Ballaz, Jara-Palomares, Luis, Martorell, Francisco Javier Rodríguez, Castro, María José, Hinojosa, Carmen Marín, López-Campos, José Luis, and Otero-Candelera, Remedios

Subjects
THROMBOEMBOLISM, OCCULTISM, CANCER patients, CASE-control method, FIBRIN fragment D
Abstract

Objectives Detecting occult cancer in patients with unprovoked venous thromboembolism (VTE) remains a significant challenge. Our objective was to investigate the potential predictive role of coagulation-related biomarkers in the diagnosis of occult malignancies. Methods We conducted a nested case-control study with a 1-year prospective cohort of 214 patients with unprovoked VTE, with a focus on identifying occult cancer. At the time of VTE diagnosis, we measured various biomarkers, including soluble P-selectin (sP-selectin), dimerized plasmin fragment D (D-dimer), platelets, leukocytes, hemoglobin, total extracellular vesicles (EVs), EVs expressing tissue factor on their surface (TF+EVs), and EVs expressing P-selectin on their surface (Psel+EVs) in all participants. Results We observed statistically significant increased levels of sP-selectin (P =.015) in patients with occult cancer. Despite an increase in Psel+EVs, TF+EVs, D-dimer, and platelets within this group, however, no significant differences were found. When sP-selectin exceeded 62 ng/mL and D-dimer surpassed 10,000 µg/L, the diagnosis of occult cancer demonstrated a specificity of up to 91% (95% CI, 79.9%-96.7%). Conclusions The combination of sP-selectin and D-dimer can be a valuable biomarker in detecting occult cancer in patients with unprovoked VTE. Further research is necessary to ascertain whether easily measurable biomarkers such as sP-selectin and D-dimer can effectively distinguish between patients who have VTE with and without hidden malignancies. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

41. Untargeted Metabolomic Study of Lung Cancer Patients after Surgery with Curative Intent

Author

Sanchez-Espirilla, Saida, primary, Pereira-Vega, Antonio, additional, Callejón-Leblic, Belén, additional, Díaz-Olivares, Isabel, additional, Santana, Rafael, additional, Gotera Rivera, Carolina, additional, Gómez-Ariza, José Luis, additional, López-Campos, José Luis, additional, Blanco-Orozco, Ana Isabel, additional, Seijo, Luis, additional, Rodríguez, María, additional, Padrón Fraysse, Luis Alejandro, additional, Herrera-Chilla, Ángeles, additional, Peces-Barba, Germán, additional, and Barrera, Tamara García, additional

Published
2023
Full Text
View/download PDF

42. Determinants of the Appearance and Progression of Early-Onset Chronic Obstructive Pulmonary Disease in Young Adults. A Case–Control Study With Follow-Up

Author

Borràs-Santos, Alícia, Garcia-Aymerich, Judith, Soler-Cataluña, Juan José, Vigil Giménez, Laura, Gea Guiral, Joaquim, Rodríguez Chiaradía, Diego, Pascual-Guardia, Sergi, Marcos Rodríguez, Pedro J., Alvarez Martinez, Carlos J., Casanova Macario, Ciro, López-Campos, José Luis, Carrasco Hernández, Laura, Martínez-González, Cristina, Santos-Pérez, Salud, Peces-Barba, Germán, Molina Paris, Jesús, Román Rodríguez, Miguel, Barberà, Joan Albert, Faner, Rosa, Agustí, Alvar, and Cosío, Borja G.

Published
2019
Full Text
View/download PDF

43. EARLY COPD: determinantes de la aparición y progresión de la enfermedad pulmonar obstructiva crónica en adultos jóvenes. Protocolo de un estudio caso-control con seguimiento

Author

Borràs-Santos, Alícia, Garcia-Aymerich, Judith, Soler-Cataluña, Juan José, Vigil Giménez, Laura, Gea Guiral, Joaquim, Rodríguez Chiaradía, Diego, Pascual-Guardia, Sergi, Marcos Rodríguez, Pedro J., Alvarez Martinez, Carlos J., Casanova Macario, Ciro, López-Campos, José Luis, Carrasco Hernández, Laura, Martínez-González, Cristina, Santos-Pérez, Salud, Peces-Barba, Germán, Molina Paris, Jesús, Román Rodríguez, Miguel, Barberà, Joan Albert, Faner, Rosa, Agustí, Alvar, and Cosío, Borja G.

Published
2019
Full Text
View/download PDF

44. The BIOMEPOC Project: Personalized Biomarkers and Clinical Profiles in Chronic Obstructive Pulmonary Disease

Author

Gea, Joaquim, Pascual, Sergi, Castro-Acosta, Ady, Hernández-Carcereny, Carmen, Castelo, Robert, Márquez-Martín, Eduardo, Montón, Concepción, Palou, Alexandre, Faner, Rosa, Furlong, Laura I., Seijo, Luis, Sanz, Ferran, Torà, Montserrat, Vilaplana, Carles, Casadevall, Carme, López-Campos, José Luis, Monsó, Eduard, Peces-Barba, Germán, Cosío, Borja G., Agustí, Alvar, Admetlló, Mireia, Alvarez-Martínez, Carlos, Barreiro, Esther, Casals, Ferran, Córdova, Rocío, García, Marian, González-García, José G., Márquez, Eduardo, Ormaza, Miren Josune, Puigdevall, Pau, Seijó, Luis, and Torralba, Yolanda

Published
2019
Full Text
View/download PDF

45. Proyecto de biomarcadores y perfiles clínicos personalizados en la enfermedad pulmonar obstructiva crónica (proyecto BIOMEPOC)

Author

Admetlló, Mireia, Agustí, Alvar, Alvarez-Martínez, Carlos, Barreiro, Esther, Casadevall, Carme, Casals, Ferran, Castelo, Robert, Castro-Acosta, Ady, Córdova, Rocío, Cosío, Borja G., Faner, Rosa, Furlong, Laura I., García, Marian, Gea, Joaquim, González-García, José G., Hernández-Carcereny, Carmen, López-Campos, José Luis, Márquez, Eduardo, Monsó, Eduard, Montón, Concepción, Ormaza, Miren Josune, Palou, Alexandre, Pascual, Sergi, Peces-Barba, Germán, Puigdevall, Pau, Sanz, Ferran, Seijó, Luis, Torà, Montserrat, Torralba, Yolanda, Vilaplana, Carles, Márquez-Martín, Eduardo, and Seijo, Luis

Published
2019
Full Text
View/download PDF

48. Metallomic Signatures of Lung Cancer and Chronic Obstructive Pulmonary Disease

Author

Callejón-Leblic, Belén, primary, Sánchez Espirilla, Saida, additional, Gotera-Rivera, Carolina, additional, Santana, Rafael, additional, Díaz-Olivares, Isabel, additional, Marín, José M., additional, Macario, Ciro Casanova, additional, Cosio, Borja García, additional, Fuster, Antonia, additional, García, Ingrid Solanes, additional, de-Torres, Juan P., additional, Feu Collado, Nuria, additional, Cabrera Lopez, Carlos, additional, Amado Diago, Carlos, additional, Romero Plaza, Amparo, additional, Fraysse, Luis Alejandro Padrón, additional, Márquez Martín, Eduardo, additional, Marín Royo, Margarita, additional, Balcells Vilarnau, Eva, additional, Llunell Casanovas, Antonia, additional, Martínez González, Cristina, additional, Galdíz Iturri, Juan Bautista, additional, Lacárcel Bautista, Celia, additional, Gómez-Ariza, José Luis, additional, Pereira-Vega, Antonio, additional, Seijo, Luis, additional, López-Campos, José Luis, additional, Peces-Barba, Germán, additional, and García-Barrera, Tamara, additional

Published
2023
Full Text
View/download PDF

49. Mortality and readmission after COPD exacerbation-related hospitalization: an individual patient data meta-analysis

Author

Waeijen-Smit, Kiki, primary, Crutsen, Mieke, additional, Keene, Spencer, additional, Miravitlles, Marc, additional, Crisafulli, Ernesto, additional, Torres, Antoni, additional, Mueller, Christian, additional, Schuetz, Philipp, additional, Ringbæk, Thomas J., additional, Fabbian, Fabio, additional, Mekov, Evgeni, additional, Harries, Timothy H., additional, Lun, Chung-Tat, additional, Ergan, Begum, additional, Esteban, Cristóbal, additional, Quintana Lopez, Jose M., additional, López-Campos, José Luis, additional, Chang, Catherina L., additional, Hancox, Robert J., additional, Shafuddin, Eskandarain, additional, Ellis, Hollie, additional, Janson, Christer, additional, Ulrik, Charlotte Suppli, additional, Gudmundsson, Gunnar, additional, Epstein, Danny, additional, Dominguez, José, additional, Lacoma, Alicia, additional, Osadnik, Christian, additional, Alia, Inmaculada, additional, Spannella, Francesco, additional, Karakurt, Zuhal, additional, Mehravaran, Hossein, additional, Utens, Cecile, additional, De Kruif, Martijn D., additional, Ko, Fanny Wai San, additional, Trethewey, Samuel P., additional, Turner, Alice M., additional, Bumbacea, Dragos, additional, Murphy, Patrick B., additional, Vermeersch, Kristina, additional, Zilberman-Itskovich, Shani, additional, Steer, John, additional, Echevarria, Carlos, additional, Bourke, Stephen C., additional, Lane, Nicholas, additional, De Batlle, Jordi, additional, Sprooten, Roy T. M., additional, Russell, Richard, additional, Faverio, Paola, additional, Cross, Jane L., additional, Prins, Hendrik J., additional, Spruit, Martijn A., additional, Simons, Sami O., additional, Houben-Wilke, Sarah, additional, and Franssen, Frits M. E., additional

Published
2023
Full Text
View/download PDF

50. Recommendations for the Implementation of the Self-Administration of Alpha-1 Antitrypsin

Author

Torres-Durán, María, primary, López-Campos, José Luis, additional, Calle Rubio, Myriam, additional, Montero-Martínez, Carmen, additional, Priegue Carrera, Ana, additional, Amaro Rodríguez, Rosanel, additional, Barrecheguren, Miriam, additional, Barrio Guirado, María Ángeles, additional, Callejas-González, Francisco Javier, additional, Casas-Maldonado, Francisco, additional, Diab-Cáceres, Layla, additional, García-Meseguer, Pilar, additional, Hernández-Pérez, José María, additional, Lázaro-Asegurado, Lourdes, additional, Martínez-González, Cristina, additional, Martínez Rivera, Carlos, additional, Michel, Francisco Javier, additional, Montoro-Ronsano, José-Bruno, additional, Sánchez, Raquel, additional, Ortiz-Pica, Marta, additional, Parra, Isabel, additional, Quintero García, José Pablo, additional, Ruiz-Serrano-de la Espada, María del Rosario, additional, Tortajada-Goitia, Begoña, additional, and Miravitlles, Marc, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results